Hyperthermia-based anti-cancer treatments

J Crezee, NAP Franken, AL Oei - Cancers, 2021 - mdpi.com
Hyperthermia is an adjuvant local anti-cancer treatment using temperatures exceeding the
physiologically optimal level, typically 40–43◦ C for approximately one hour. Hyperthermia …

Complications and mortality rate of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Italian peritoneal surface malignancies oncoteam results …

F Carboni, M Valle, M Vaira, P Sammartino, O Federici… - Cancers, 2022 - mdpi.com
Simple Summary Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy has
been introduced in order to improve outcomes for selected patients with peritoneal surface …

Peritoneal surface malignancies originating from urachal carcinoma: case reports and review of the literature

P Van Breusegem, G Verswijvel, S Fransis… - Indian Journal of …, 2023 - Springer
Urachal carcinoma (UC) is a rare and aggressive tumor arising from the urachal remnants,
with the potential for peritoneal dissemination. Patients diagnosed with UC often have a …

Morbidity and mortality of patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

G Hotza, M Karageorgos, V Pastourmatzi… - Discover Oncology, 2024 - Springer
Background The purpose of this study was to record the incidence, and identify the
prognostic variables of morbidity and mortality in patients with peritoneal malignancy …

[PDF][PDF] Hyperthermia-Based Anti-Cancer Treatments. Cancers 2021, 13, 1240

J Crezee, NAP Franken, AL Oei - Google Scholar, 2021 - researchgate.net
Hyperthermia is an adjuvant local anti-cancer treatment using temperatures exceeding the
physiologically optimal level, typically 40–43◦ C for approximately one hour. Hyperthermia …